News

According to the company, ColonSentry is the world’s first blood-based test that assesses a patient’s current risk of having colorectal cancer, identifying those in the asymptomatic general population

The Phase III trial is a randomized, placebo-controlled, double-blinded study of XL184 as single-agent therapy in 315 patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).

Graceptor is a once-daily modified release formulation of Astella’s Prograf (tacrolimus, twice-daily formulation). Tacrolimus works as an immunosuppressant by inhibiting production of cytokinine including differentiation or growth factor

The agreement provides for a payment to Biota of A$20 million, with each party bearing their own litigation costs. The payment will be made on August 18, 2008.

The patent grant ensures that the novel disposable cassette system and the key elements of the detection technology employed in Afinion are protected from copying by third parties.

According to the company, the weight control group – which markets Alli diet pills – and the smoking cessation group – which includes the NicoDerm, Nicorette and Commit

Under the current system, the use of unauthorized medicines or the off-label prescribing of an authorized drug must be approved by the Spanish medicines agency, AEMPS, on a

Proteoderm has created an anti-aging and anti-wrinkle product line that is said to enhance the skin’s firmness and elasticity and promotes the skin’s natural moisture production activity. Unlike

The market launch in Germany is delayed preliminarily because the originator firm Sanofi-Aventis has challenged the approval as has been expected. For the time being, this prevents the